Zheng Tao, Zhu Zhou
Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle 1A.27, Baltimore, MD 21224, USA.
Curr Allergy Asthma Rep. 2005 Jul;5(4):291-7. doi: 10.1007/s11882-005-0069-x.
Atopic dermatitis (AD) is a complex disease that manifests immunologic abnormalities in the skin. The immunologic changes of AD are characterized by a T helper cell type 2 (Th2)-dominated immune response in its acute phase and a Th1/Th2 mixed immune response in its chronic phase. Although the clinical presentation and pathologic changes are initially in the skin, AD may be, in part, a systemic disorder. In fact, AD is often considered to be the initial manifestation of the "atopic march" that progresses from AD to allergic rhinitis and asthma. In the past several years, a number of murine models of AD have been developed or discovered, and studies on these models have contributed greatly to our understanding of the immunopathogenesis of this disease. This review is focused on these recent, illuminating advances in animal models of AD.
特应性皮炎(AD)是一种在皮肤中表现出免疫异常的复杂疾病。AD的免疫变化特征为急性期以2型辅助性T细胞(Th2)主导的免疫反应,慢性期为Th1/Th2混合免疫反应。尽管临床表现和病理变化最初出现在皮肤,但AD可能部分是一种全身性疾病。事实上,AD常被认为是“特应性进程”的初始表现,该进程从AD发展为过敏性鼻炎和哮喘。在过去几年中,已开发或发现了多种AD小鼠模型,对这些模型的研究极大地促进了我们对该疾病免疫发病机制的理解。本综述聚焦于AD动物模型的这些最新且具有启发性的进展。